297 related articles for article (PubMed ID: 29781543)
1. Prospective predictors of exacerbation status in severe asthma over a 3-year follow-up.
Kimura H; Konno S; Makita H; Taniguchi N; Shimizu K; Suzuki M; Kimura H; Goudarzi H; Nakamaru Y; Ono J; Ohta S; Izuhara K; Ito YM; Wenzel SE; Nishimura M;
Clin Exp Allergy; 2018 Sep; 48(9):1137-1146. PubMed ID: 29781543
[TBL] [Abstract][Full Text] [Related]
2. Predicting future risk of exacerbations in Japanese patients with adult asthma: A prospective 1-year follow up study.
Tanaka A; Uno T; Sato H; Jinno M; Hirai K; Miyata Y; Yamaguchi M; Ohta S; Homma T; Yamamoto M; Suzuki S; Yokoe T; Sagara H
Allergol Int; 2017 Oct; 66(4):568-573. PubMed ID: 28318883
[TBL] [Abstract][Full Text] [Related]
3. Determination of the cutoff values of Th2 markers for the prediction of future exacerbation in severe asthma: An analysis from the Hokkaido Severe Asthma Cohort Study.
Kimura H; Makita H; Taniguchi N; Takei N; Matsumoto M; Kimura H; Goudarzi H; Shimizu K; Suzuki M; Nishimura M; Konno S;
Allergol Int; 2021 Jan; 70(1):68-73. PubMed ID: 32952040
[TBL] [Abstract][Full Text] [Related]
4. Disconnect of type 2 biomarkers in severe asthma; dominated by FeNO as a predictor of exacerbations and periostin as predictor of reduced lung function.
Mansur AH; Srivastava S; Sahal A
Respir Med; 2018 Oct; 143():31-38. PubMed ID: 30261989
[TBL] [Abstract][Full Text] [Related]
5. Type 2 Biomarkers and Prediction of Future Exacerbations and Lung Function Decline in Adult Asthma.
Semprini R; Williams M; Semprini A; McDouall A; Fingleton J; Holweg C; Weatherall M; Beasley R; Braithwaite I
J Allergy Clin Immunol Pract; 2018; 6(6):1982-1988.e1. PubMed ID: 29609049
[TBL] [Abstract][Full Text] [Related]
6. Inflammatory and Comorbid Features of Patients with Severe Asthma and Frequent Exacerbations.
Denlinger LC; Phillips BR; Ramratnam S; Ross K; Bhakta NR; Cardet JC; Castro M; Peters SP; Phipatanakul W; Aujla S; Bacharier LB; Bleecker ER; Comhair SA; Coverstone A; DeBoer M; Erzurum SC; Fain SB; Fajt M; Fitzpatrick AM; Gaffin J; Gaston B; Hastie AT; Hawkins GA; Holguin F; Irani AM; Israel E; Levy BD; Ly N; Meyers DA; Moore WC; Myers R; Opina MT; Peters MC; Schiebler ML; Sorkness RL; Teague WG; Wenzel SE; Woodruff PG; Mauger DT; Fahy JV; Jarjour NN;
Am J Respir Crit Care Med; 2017 Feb; 195(3):302-313. PubMed ID: 27556234
[TBL] [Abstract][Full Text] [Related]
7. Role of spirometry and exhaled nitric oxide to predict exacerbations in treated asthmatics.
Gelb AF; Flynn Taylor C; Shinar CM; Gutierrez C; Zamel N
Chest; 2006 Jun; 129(6):1492-9. PubMed ID: 16778266
[TBL] [Abstract][Full Text] [Related]
8. Elevated levels of circulating CD4(+) CRTh2(+) T cells characterize severe asthma.
Palikhe NS; Laratta C; Nahirney D; Vethanayagam D; Bhutani M; Vliagoftis H; Cameron L
Clin Exp Allergy; 2016 Jun; 46(6):825-36. PubMed ID: 27079298
[TBL] [Abstract][Full Text] [Related]
9. Alveolar Nitric Oxide and Peripheral Oxygen Saturation in Frequent Exacerbators with Asthma: A Pilot Study.
Sprio AE; Bertolini F; Fucà R; Levra S; Carriero V; Högman M; Ricciardolo FLM
Int Arch Allergy Immunol; 2022; 183(1):105-115. PubMed ID: 34515153
[TBL] [Abstract][Full Text] [Related]
10. Comparative features of Asthma with frequent or infrequent exacerbations: A longitudinal study of retrospective and prospective events.
Boulay MÈ; Pruneau-Pomerleau C; Villeneuve H; Deschesnes F; Ringuette L; Boulet LP
J Asthma; 2018 Mar; 55(3):231-243. PubMed ID: 29020468
[TBL] [Abstract][Full Text] [Related]
11. Long-term future risk of severe exacerbations: Distinct 5-year trajectories of problematic asthma.
Yii ACA; Tan JHY; Lapperre TS; Chan AKW; Low SY; Ong TH; Tan KL; Chotirmall SH; Sterk PJ; Koh MS
Allergy; 2017 Sep; 72(9):1398-1405. PubMed ID: 28295424
[TBL] [Abstract][Full Text] [Related]
12. Frequent exacerbators--a distinct phenotype of severe asthma.
Kupczyk M; ten Brinke A; Sterk PJ; Bel EH; Papi A; Chanez P; Nizankowska-Mogilnicka E; Gjomarkaj M; Gaga M; Brusselle G; Dahlén B; Dahlén SE;
Clin Exp Allergy; 2014 Feb; 44(2):212-21. PubMed ID: 24447083
[TBL] [Abstract][Full Text] [Related]
13. Ability of Exhaled Nitric Oxide to Discriminate for Airflow Obstruction Among Frequent Exacerbators of Clinically Diagnosed Asthma.
Jalota L; Allison DR; Prajapati V; Vempilly JJ; Jain VV
Lung; 2018 Aug; 196(4):455-462. PubMed ID: 29916097
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal trajectories of severe wheeze exacerbations from infancy to school age and their association with early-life risk factors and late asthma outcomes.
Deliu M; Fontanella S; Haider S; Sperrin M; Geifman N; Murray C; Simpson A; Custovic A
Clin Exp Allergy; 2020 Mar; 50(3):315-324. PubMed ID: 31876035
[TBL] [Abstract][Full Text] [Related]
15. Airway IL-1β and Systemic Inflammation as Predictors of Future Exacerbation Risk in Asthma and COPD.
Fu JJ; McDonald VM; Baines KJ; Gibson PG
Chest; 2015 Sep; 148(3):618-629. PubMed ID: 25950204
[TBL] [Abstract][Full Text] [Related]
16. Simultaneously elevated exhaled nitric oxide and serum-eosinophil cationic protein relate to recent asthma events in asthmatics in a cross-sectional population-based study.
Mogensen I; Alving K; Bjerg A; Borres MP; Hedlin G; Sommar J; Dahlén SE; Janson C; Malinovschi A
Clin Exp Allergy; 2016 Dec; 46(12):1540-1548. PubMed ID: 27513280
[TBL] [Abstract][Full Text] [Related]
17. Exacerbation Profile and Risk Factors in a Type-2-Low Enriched Severe Asthma Cohort: A Clinical Trial to Assess Asthma Exacerbation Phenotypes.
McDowell PJ; Busby J; Hanratty CE; Djukanovic R; Woodcock A; Walker S; Hardman TC; Arron JR; Choy DF; Bradding P; Brightling CE; Chaudhuri R; Cowan D; Mansur AH; Fowler SJ; Diver SE; Howarth P; Lordan J; Menzies-Gow A; Harrison T; Robinson DS; Holweg CTJ; Matthews JG; Pavord ID; Heaney LG
Am J Respir Crit Care Med; 2022 Sep; 206(5):545-553. PubMed ID: 35549845
[No Abstract] [Full Text] [Related]
18. "Frequent exacerbator" is a phenotype of poor prognosis in Japanese patients with chronic obstructive pulmonary disease.
Tomioka R; Kawayama T; Suetomo M; Kinoshita T; Tokunaga Y; Imaoka H; Matsunaga K; Okamoto M; Hoshino T
Int J Chron Obstruct Pulmon Dis; 2016; 11():207-16. PubMed ID: 26893552
[TBL] [Abstract][Full Text] [Related]
19. Exacerbation risk in severe asthma is stratified by inflammatory phenotype using longitudinal measures of sputum eosinophils.
Walsh CJ; Zaihra T; Benedetti A; Fugère C; Olivenstein R; Lemière C; Hamid Q; Martin JG
Clin Exp Allergy; 2016 Oct; 46(10):1291-302. PubMed ID: 27214328
[TBL] [Abstract][Full Text] [Related]
20. Exacerbation Patterns in Adults with Asthma in England. A Population-based Study.
Bloom CI; Palmer T; Feary J; Quint JK; Cullinan P
Am J Respir Crit Care Med; 2019 Feb; 199(4):446-453. PubMed ID: 30507307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
